Untreated Crohn’s disease causes progressive, irreversible damage to the digestive tract and can affect nearly every organ system in the body. What starts as inflammation in the gut lining gradually deepens into the intestinal wall, leading to complications like narrowed passages, abnormal tunnels between organs, and chronic malnutrition. Up to 50% of people with Crohn’s develop fistulas within 20 years of diagnosis, and the overall mortality rate runs about 50% to 85% higher than the general population.
How Inflammation Becomes Permanent Damage
Crohn’s inflammation isn’t like a cut that heals cleanly. Every time the gut wall becomes inflamed, the body sends repair cells to patch it up. In normal wound healing, those repair cells do their job and leave. In Crohn’s, the inflammation never fully resolves, so the repair process runs on a loop. The cells responsible for healing keep producing scar tissue and depositing structural proteins where healthy, flexible tissue used to be.
Over time, the gut lining itself transforms. Cells that once formed the intestinal barrier gradually shift into scar-producing cells, losing their original function entirely. This process is irreversible. The intestinal wall becomes thickened, rigid, and disorganized, replacing the normal architecture that allows the gut to absorb nutrients and move food along. This is the core reason untreated Crohn’s gets worse rather than burning itself out: the longer inflammation persists, the more healthy tissue converts to non-functional scar tissue.
Strictures, Fistulas, and Abscesses
The structural complications of unchecked Crohn’s fall into three main categories, and they often overlap.
Strictures are sections of intestine that have narrowed due to scarring. They act like a bottleneck, making it harder for food to pass through. Symptoms include cramping after meals, bloating, nausea, and eventually vomiting if the blockage becomes severe enough. Strictures frequently require surgical removal of the affected segment.
Fistulas are abnormal tunnels that form when inflammation burrows all the way through the intestinal wall and into an adjacent structure. They can connect one section of bowel to another, or the bowel to the bladder, vagina, or skin surface. Up to 50% of Crohn’s patients develop fistulas within 20 years, and 71% to 84% of anal fistulas in Crohn’s are classified as complex, meaning they involve multiple tracts or associated complications. Fistulas between the intestine and bladder allow gut contents to leak into the urinary system, causing recurrent infections. Fistulas to the skin create draining wounds that don’t heal on their own.
Abscesses are pockets of infection that form when bacteria escape through damaged intestinal walls. They can develop anywhere in the abdomen or around the anus and typically cause fever, localized pain, and swelling. Without drainage and treatment, abscesses can become life-threatening.
Malnutrition and Deficiencies
Crohn’s most commonly affects the small intestine, which is where the body absorbs the majority of its nutrients. Chronic inflammation in this area disrupts absorption of iron, B12, folate, and fat-soluble vitamins like A, D, and E. In one clinical study, 36% of malnourished Crohn’s patients required intravenous iron because oral supplements couldn’t compensate for the degree of malabsorption.
The consequences of these deficiencies compound over time. Iron and B12 deficiency cause anemia, leading to fatigue, weakness, and difficulty concentrating. Vitamin D deficiency accelerates bone loss, and osteoporosis is a recognized complication of long-standing Crohn’s. Poor nutrient absorption also drives weight loss, muscle wasting, and a weakened immune system, which in turn makes the gut more vulnerable to infection and slower to heal.
Effects Beyond the Gut
Crohn’s is a systemic inflammatory disease, not just a bowel condition. The same immune dysfunction that attacks the intestines can target joints, skin, eyes, the liver, and the kidneys.
Joint pain is the most common issue outside the gut, affecting 9% to 53% of people with inflammatory bowel disease. It can involve the knees, ankles, wrists, spine, or sacroiliac joints. Unlike typical arthritis, it often flares alongside intestinal symptoms.
Skin manifestations appear in 2% to 34% of patients. The two most common are erythema nodosum, which causes tender red nodules on the shins, and pyoderma gangrenosum, which produces deep, painful ulcers that can appear anywhere on the body. Mouth ulcers are also frequent.
Eye inflammation occurs in up to 5% of patients and ranges from mild redness and irritation (episcleritis) to more serious conditions that can impair vision, including uveitis and scleritis. These eye complications often appear alongside joint and skin symptoms.
Gallstones and kidney stones also occur at higher rates in Crohn’s patients, particularly when the ileum (the last section of the small intestine) is inflamed or has been surgically removed.
Colorectal Cancer Risk
Chronic, uncontrolled inflammation in the colon significantly raises the risk of colorectal cancer. One study found that Crohn’s patients developed colorectal cancer at roughly 20 times the rate of the general population, though other estimates place the increase at around 4-fold. The risk climbs the longer the disease has been active and the more colon tissue is involved. This is one reason regular colonoscopy surveillance matters for anyone with long-standing Crohn’s affecting the colon.
Growth Failure in Children
For children and adolescents, untreated Crohn’s carries an additional and time-sensitive risk: impaired growth. Between 15% and 40% of children with Crohn’s already show growth failure at the time of diagnosis. In many cases, slowed growth actually appears before any obvious digestive symptoms, meaning the disease may be silently undermining development for months or years before it’s caught.
The mechanism is twofold. Chronic inflammation floods the body with signals that interfere with growth hormone activity, effectively making the body resistant to its own growth signals. At the same time, poor appetite and malabsorption deprive the body of the calories and nutrients needed to grow. Children diagnosed before puberty face the highest risk of reduced final adult height, and while treatment can partially recover lost growth, some deficit often remains permanent.
Impact on Daily Life and Independence
Active, uncontrolled Crohn’s takes a heavy toll on daily functioning. Frequent diarrhea, abdominal pain, fatigue, and the unpredictability of flares make it difficult to hold a job, attend school, or maintain social relationships. Weight loss of more than 5 kilograms at diagnosis is recognized as a predictor of a more aggressive disease course. Hospitalizations and surgeries become more likely over time, and each surgery removes functional intestine that doesn’t regenerate.
Current treatment guidelines now include restoration of quality of life and absence of disability as core long-term goals alongside healing the intestinal lining. This reflects a growing recognition that controlling inflammation isn’t just about preventing complications on a scan. It’s about preserving the ability to live a normal life.
Mortality
Multiple population studies across Europe and the United States have found that people with Crohn’s disease have a mortality rate 20% to 85% higher than the general population. The most consistent estimates fall around 50% excess mortality. A UK study using a large medical database found the overall standardized mortality ratio to be 1.7, meaning Crohn’s patients were 70% more likely to die during the study period than matched controls.
The leading Crohn’s-related causes of death include postoperative infections, bowel infarction (loss of blood supply to the intestine), toxic megacolon, and sepsis. In one cohort, 38% of all deaths were judged to be directly or possibly related to Crohn’s disease. People with active disease also had higher cardiovascular death rates, particularly in the period around surgery. Gastrointestinal causes unrelated to cancer were the most disproportionately elevated category of death compared to the general population.